Application Effect of PDCA in Reducing the Incidence of Subcutaneous Ecchymosis of Patients With Self-Injected Pre-Perfusion Low Molecular Weight Heparin Sodium
Objective To investigate the application effect of plan-do-check-act (PDCA) cycle in reducing the incidence of subcutaneous ecchymosis of patients with self-injected pre-perfusion low molecular weight heparin sodium. Methods A total of 56 patients who were treated in the First Affiliated Hospital of Xiamen University from March to May 2023 and self-injected pre-perfusion low molecular weight heparin sodium were selected as the control group. A total of 49 patients who were self-injected pre-perfusion low molecular weight heparin sodium from August to October 2023 were selected as the observation group. The control group was guided by the conventional injection process,and the observation group was treated with PDCA cycle tool for injection intervention management. The incidence of subcutaneous ecchymosis by self-injected pre-perfusion low molecular weight heparin sodium was compared between the two groups. Results In the observation group,the incidence of non-rotation of injection site was 20.4％,the incidence of injection without air bubble was 18.4％,the incidence of inaccurate compression technique was 16.3％,the incidence of inaccurate injection depth was 6.1％,and the incidence of insufficient compression time was 4.1％,which were lower than 44.6％,39.3％,35.7％,19.6％,17.9％ in the control group,the difference was statistically significant (P<0.05). The pain degree of the observation group was better than that of the control group,and the difference was statistically significant (P<0.05). The incidence of subcutaneous ecchymosis in the observation group was 12.2％,which was lower than 33.9％ in the control group,and the difference was statistically significant (P<0.05). Conclusion The application of PDCA cycle tool can help reduce the incidence of subcutaneous ecchymosis of patients who were self-injected pre-perfusion low molecular weight heparin sodium.
万方数据
维普
